8.8(top 1%)
Impact Factor
9.6(top 1%)
extended IF
163(top 2%)
H-Index
4.4K
authors
6.4K
papers
221.6K
citations
6.1K
citing journals
50.8K
citing authors

Most Cited Articles of European Journal of Nuclear Medicine and Molecular Imaging

TitleYearCitations
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.020151.4K
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.02010959
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use2000754
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer2015745
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer2014681
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions2013634
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD2005626
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-22020486
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours2013462
Guidelines for radioiodine therapy of differentiated thyroid cancer2008445
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study2003438
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting2003427
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology2005405
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region2002403
Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.02017399
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data2001398
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours2007392
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 22009377
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer1998360
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT2009357
Myocardial perfusion scintigraphy: the evidence2004352
Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients2017343
A gradient-based method for segmenting FDG-PET images: methodology and validation2007328
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis2013326
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers2008324